Zynerba Pharmaceuticals Initiates Phase 1 Clinical Trial for ZYN002 CBD Gel
October 20, 2015 at 07:06 AM EDT
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) today announced the initiation of a Phase 1 clinical trial for its ZYN002 cannabidiol (CBD) ...